SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001387131-21-004924
Filing Date
2021-04-26
Accepted
2021-04-26 16:34:16
Documents
2
Group Members
MAMOURA DIVERSIFIED GLOBAL HOLDINGS PJSCMDC CAPITAL PARTNERS (VENTURES) GP, LPMDC CAPITAL PARTNERS (VENTURES), LPMIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLCMIC CAPITAL PARTNERS (PUBLIC) PARALLEL CAYMAN, LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP mubadala-sc13d_042621.htm SC 13D 121968
2 AGREEMENT OF JOINT FILING ex1.htm EX-1 6677
  Complete submission text file 0001387131-21-004924.txt   130503
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Subject) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92498 | Film No.: 21854313
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P.O. BOX 45005 ABU DHABI C0 00000
Business Address P.O. BOX 45005 ABU DHABI C0 00000 971-2413-0000
Mubadala Investment Co PJSC (Filed by) CIK: 0001704268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C0 | Fiscal Year End: 1231
Type: SC 13D